Jiangshan Wan

775 citations
14 papers · 671 indexed · h-index 13
Topics
Nanoparticle-Based Drug Delivery (8 papers)Nanoplatforms for cancer theranostics (8 papers)Gold and Silver Nanoparticles Synthesis and Applications (4 papers)
Partner nations
ChinaUnited States

In The Last Decade

Jiangshan Wan

14 papers receiving 670 citations

Peers

Jiangshan Wan
Comparison fields: 5 of 77
  • Biomedical Engineering 392
  • Materials Chemistry 245
  • Biomaterials 228
  • Molecular Biology 157
  • Spectroscopy 64
Replace Chengfan Wu with:
Chengfan Wu China
Jiaojun Wei China
Chai Hoon Quek United States
Qingdi Zhu Singapore
Italo Rodrigo Calori Brazil
Jun Tao China
Hao Zhao China
Minhee Ku South Korea
Shi Gao China
Mengmeng Hou China
Jiangshan Wan relative to Chengfan Wu China Chengfan Wu's profile →
Citations per field
00.5×10×14×
Chengfan Wu · 1×
Citations per year

Countries citing papers authored by Jiangshan Wan

Since Specialization
Citations

This map shows the geographic impact of Jiangshan Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangshan Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangshan Wan more than expected).

Fields of papers citing papers by Jiangshan Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiangshan Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangshan Wan. The network helps show where Jiangshan Wan may publish in the future.

Co-authorship network of co-authors of Jiangshan Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Jiangshan Wan. A scholar is included among the top collaborators of Jiangshan Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiangshan Wan. Jiangshan Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 29
2 44
3 32
4 63
5 53
6 27
7 50
8 97
9 24
10 43
11 66
12 6
13 116
14 21

About Jiangshan Wan

Jiangshan Wan is a scholar working on Biomaterials, Biomedical Engineering and Electronic, Optical and Magnetic Materials, having authored 14 papers that have together received 671 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (8 papers), Nanoplatforms for cancer theranostics (8 papers) and Gold and Silver Nanoparticles Synthesis and Applications (4 papers). The work is most often cited by research in Biomaterials (228 citations), Molecular Medicine (47 citations) and Biomedical Engineering (392 citations). Jiangshan Wan has collaborated with scholars based in China and United States. Frequent co-authors include Yanbing Zhao, Xiangliang Yang, Hao Zhao, Yufeng Zhang, Yulan Wang, Lu Gan, Xiaole Peng, Huibi Xu, Richard J. Miron and Shinan Geng. Their work appears in journals such as ACS Applied Materials & Interfaces, Journal of Controlled Release and Nanoscale.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026